aluates Reports

$ 0.0

Automative

Global Infertility Services Market Research Report 2026

Published Date: 2026-02-11

Report Code: QYRE-Auto-3I6321

Global Infertility Services Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Infertility Services Market Research Report 2026

Code: QYRE-Auto-3I6321

Report

2026-02-11

Pages:133

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CARE facility

CooperSurgical

Ferring Pharmaceuticals

Monash IVF

Merck

Vitrolife AB

INVO Bioscience

Irvine Scientific

NMC Health

OB GYN Associates

TriHealth

Virtus Health

Mayo Clinic

LIVZON

Abbott

Theramex

Cinnagen

InVitroCare

Jinxin Fertility

Caerus Biotech

Infertility Services Market Size

The global Infertility Services market was valued at US$ 8212 million in 2025 and is anticipated to reach US$ 13450 million by 2032, at a CAGR of 7.4% from 2026 to 2032.

Infertility Services Market

Infertility services refer to medical procedures and treatments that are designed to help individuals or couples who are experiencing difficulties in conceiving a child. These services aim to diagnose and treat the underlying causes of infertility, and potentially assist in achieving a successful pregnancy.

Infertility services have become an important part of the global medical field in recent years. With the change of lifestyle, the influence of environmental factors and the change of fertility concepts, infertility has gradually become an important social and health issue worldwide. According to statistics from the World Health Organization (WHO), about 10-15% of couples in the world face infertility problems. This proportion varies in different countries and regions, but the prevalence of this problem has prompted the rapid development of the infertility treatment market.

At present, the scale of the infertility service market is growing globally and is expected to continue to grow in the next few years. The rapid development of assisted reproductive technology (ART) has given hope to many couples who were once unable to get pregnant. The maturity of technologies such as in vitro fertilization (IVF), egg freezing, intracytoplasmic sperm injection (ICSI), and embryo genetic screening (PGS/PGD) has not only increased the success rate, but also allowed more infertile patients to enjoy treatment. In addition, with the advancement of genetic testing technology, the popularization of preimplantation genetic screening can effectively reduce the risk of chromosomal abnormalities and increase the chance of successful pregnancy.

Despite the rapid growth of the infertility service market, it still faces some challenges and problems:

High treatment costs: Assisted reproductive technologies such as IVF are expensive and not all families can afford them. Especially in some developing countries or regions, although the technology is gradually becoming popular, the cost of treatment is still a major obstacle. Therefore, how to reduce treatment costs and provide more economical treatment options is still a difficult problem that needs to be solved. Differences in technology accessibility: Although some advanced assisted reproductive technologies have been popularized in some developed countries, in many developing countries and regions, these technologies are not yet popular and the accessibility of treatment is low. In addition, the imbalance of medical facilities has caused a gap in the treatment of infertility in patients in different regions and industries.

With the continuous advancement of science and technology and the increase in social needs, the future development trend of the infertility service market is becoming clearer and clearer.

The core manufacturers of global infertility services include Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic and LIVZON. The top three manufacturers account for approximately 24% of the global share. The Asia-Pacific region is the world's largest market, accounting for nearly 45% of the market share.

In terms of product type, assisted reproductive technology (ART) occupies a dominant position, accounting for 62% of the market share. At the same time, in terms of application, females are the largest application field, accounting for 66%.

This report delivers a comprehensive overview of the global Infertility Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infertility Services. The Infertility Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Infertility Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Infertility Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Infertility Services Market Report

Report Metric	Details
Report Name	Infertility Services Market
Accounted market size in 2025	US$ 8212 million
Forecasted market size in 2032	US$ 13450 million
CAGR	7.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Assisted Reproductive Technology (ART) Infertility Drug Services Others
Segment by Application	Male Female
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic, LIVZON, Abbott, Monash IVF, CARE Facility, Theramex, TriHealth, NMC Health, CooperSurgical, Irvine Scientific, Virtus Health, CinnaGen, OB GYN Associates, Caerus Biotech, InVitroCare, INVO Bioscience
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Infertility Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Infertility Services Market growing?

Ans: The Infertility Services Market witnessing a CAGR of 7.4% during the forecast period 2026-2032.

What is the Infertility Services Market size in 2032?

Ans: The Infertility Services Market size in 2032 will be US$ 13450 million.

What is the market share of major companies in Infertility Services Market?

Ans: The top three manufacturers account for approximately 24% of the global share.

What is the Infertility Services Market share by region?

Ans: The Asia-Pacific region is the world's largest market, accounting for nearly 45% of the market share.

What is the Infertility Services Market share by type?

Ans: In terms of product type, assisted reproductive technology (ART) occupies a dominant position, accounting for 62% of the market share.

Who are the main players in the Infertility Services Market report?

Ans: The main players in the Infertility Services Market are Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic, LIVZON, Abbott, Monash IVF, CARE Facility, Theramex, TriHealth, NMC Health, CooperSurgical, Irvine Scientific, Virtus Health, CinnaGen, OB GYN Associates, Caerus Biotech, InVitroCare, INVO Bioscience

What are the Application segmentation covered in the Infertility Services Market report?

Ans: The Applications covered in the Infertility Services Market report are Male, Female

What are the Type segmentation covered in the Infertility Services Market report?

Ans: The Types covered in the Infertility Services Market report are Assisted Reproductive Technology (ART), Infertility Drug Services, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infertility Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Assisted Reproductive Technology (ART)

1.2.3 Infertility Drug Services

1.2.4 Others

1.3 Market by Application

1.3.1 Global Infertility Services Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Male

1.3.3 Female

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infertility Services Market Perspective (2021–2032)

2.2 Global Infertility Services Growth Trends by Region

2.2.1 Global Infertility Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Infertility Services Historic Market Size by Region (2021–2026)

2.2.3 Infertility Services Forecasted Market Size by Region (2027–2032)

2.3 Infertility Services Market Dynamics

2.3.1 Infertility Services Industry Trends

2.3.2 Infertility Services Market Drivers

2.3.3 Infertility Services Market Challenges

2.3.4 Infertility Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infertility Services Players by Revenue

3.1.1 Global Top Infertility Services Players by Revenue (2021–2026)

3.1.2 Global Infertility Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Infertility Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Infertility Services Revenue

3.4 Global Infertility Services Market Concentration Ratio

3.4.1 Global Infertility Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infertility Services Revenue in 2025

3.5 Global Key Players of Infertility Services Head Offices and Areas Served

3.6 Global Key Players of Infertility Services, Products and Applications

3.7 Global Key Players of Infertility Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Infertility Services Breakdown Data by Type

4.1 Global Infertility Services Historic Market Size by Type (2021–2026)

4.2 Global Infertility Services Forecasted Market Size by Type (2027–2032)

5 Infertility Services Breakdown Data by Application

5.1 Global Infertility Services Historic Market Size by Application (2021–2026)

5.2 Global Infertility Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Infertility Services Market Size (2021–2032)

6.2 North America Infertility Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Infertility Services Market Size by Country (2021–2026)

6.4 North America Infertility Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infertility Services Market Size (2021–2032)

7.2 Europe Infertility Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Infertility Services Market Size by Country (2021–2026)

7.4 Europe Infertility Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Infertility Services Market Size (2021–2032)

8.2 Asia-Pacific Infertility Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Infertility Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Infertility Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Infertility Services Market Size (2021–2032)

9.2 Latin America Infertility Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Infertility Services Market Size by Country (2021–2026)

9.4 Latin America Infertility Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infertility Services Market Size (2021–2032)

10.2 Middle East & Africa Infertility Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Infertility Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Infertility Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ferring Pharmaceuticals

11.1.1 Ferring Pharmaceuticals Company Details

11.1.2 Ferring Pharmaceuticals Business Overview

11.1.3 Ferring Pharmaceuticals Infertility Services Introduction

11.1.4 Ferring Pharmaceuticals Revenue in Infertility Services Business (2021–2026)

11.1.5 Ferring Pharmaceuticals Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Infertility Services Introduction

11.2.4 Merck Revenue in Infertility Services Business (2021–2026)

11.2.5 Merck Recent Development

11.3 Jinxin Fertility

11.3.1 Jinxin Fertility Company Details

11.3.2 Jinxin Fertility Business Overview

11.3.3 Jinxin Fertility Infertility Services Introduction

11.3.4 Jinxin Fertility Revenue in Infertility Services Business (2021–2026)

11.3.5 Jinxin Fertility Recent Development

11.4 Vitrolife

11.4.1 Vitrolife Company Details

11.4.2 Vitrolife Business Overview

11.4.3 Vitrolife Infertility Services Introduction

11.4.4 Vitrolife Revenue in Infertility Services Business (2021–2026)

11.4.5 Vitrolife Recent Development

11.5 Mayo Clinic

11.5.1 Mayo Clinic Company Details

11.5.2 Mayo Clinic Business Overview

11.5.3 Mayo Clinic Infertility Services Introduction

11.5.4 Mayo Clinic Revenue in Infertility Services Business (2021–2026)

11.5.5 Mayo Clinic Recent Development

11.6 LIVZON

11.6.1 LIVZON Company Details

11.6.2 LIVZON Business Overview

11.6.3 LIVZON Infertility Services Introduction

11.6.4 LIVZON Revenue in Infertility Services Business (2021–2026)

11.6.5 LIVZON Recent Development

11.7 Abbott

11.7.1 Abbott Company Details

11.7.2 Abbott Business Overview

11.7.3 Abbott Infertility Services Introduction

11.7.4 Abbott Revenue in Infertility Services Business (2021–2026)

11.7.5 Abbott Recent Development

11.8 Monash IVF

11.8.1 Monash IVF Company Details

11.8.2 Monash IVF Business Overview

11.8.3 Monash IVF Infertility Services Introduction

11.8.4 Monash IVF Revenue in Infertility Services Business (2021–2026)

11.8.5 Monash IVF Recent Development

11.9 CARE Facility

11.9.1 CARE Facility Company Details

11.9.2 CARE Facility Business Overview

11.9.3 CARE Facility Infertility Services Introduction

11.9.4 CARE Facility Revenue in Infertility Services Business (2021–2026)

11.9.5 CARE Facility Recent Development

11.10 Theramex

11.10.1 Theramex Company Details

11.10.2 Theramex Business Overview

11.10.3 Theramex Infertility Services Introduction

11.10.4 Theramex Revenue in Infertility Services Business (2021–2026)

11.10.5 Theramex Recent Development

11.11 TriHealth

11.11.1 TriHealth Company Details

11.11.2 TriHealth Business Overview

11.11.3 TriHealth Infertility Services Introduction

11.11.4 TriHealth Revenue in Infertility Services Business (2021–2026)

11.11.5 TriHealth Recent Development

11.12 NMC Health

11.12.1 NMC Health Company Details

11.12.2 NMC Health Business Overview

11.12.3 NMC Health Infertility Services Introduction

11.12.4 NMC Health Revenue in Infertility Services Business (2021–2026)

11.12.5 NMC Health Recent Development

11.13 CooperSurgical

11.13.1 CooperSurgical Company Details

11.13.2 CooperSurgical Business Overview

11.13.3 CooperSurgical Infertility Services Introduction

11.13.4 CooperSurgical Revenue in Infertility Services Business (2021–2026)

11.13.5 CooperSurgical Recent Development

11.14 Irvine Scientific

11.14.1 Irvine Scientific Company Details

11.14.2 Irvine Scientific Business Overview

11.14.3 Irvine Scientific Infertility Services Introduction

11.14.4 Irvine Scientific Revenue in Infertility Services Business (2021–2026)

11.14.5 Irvine Scientific Recent Development

11.15 Virtus Health

11.15.1 Virtus Health Company Details

11.15.2 Virtus Health Business Overview

11.15.3 Virtus Health Infertility Services Introduction

11.15.4 Virtus Health Revenue in Infertility Services Business (2021–2026)

11.15.5 Virtus Health Recent Development

11.16 CinnaGen

11.16.1 CinnaGen Company Details

11.16.2 CinnaGen Business Overview

11.16.3 CinnaGen Infertility Services Introduction

11.16.4 CinnaGen Revenue in Infertility Services Business (2021–2026)

11.16.5 CinnaGen Recent Development

11.17 OB GYN Associates

11.17.1 OB GYN Associates Company Details

11.17.2 OB GYN Associates Business Overview

11.17.3 OB GYN Associates Infertility Services Introduction

11.17.4 OB GYN Associates Revenue in Infertility Services Business (2021–2026)

11.17.5 OB GYN Associates Recent Development

11.18 Caerus Biotech

11.18.1 Caerus Biotech Company Details

11.18.2 Caerus Biotech Business Overview

11.18.3 Caerus Biotech Infertility Services Introduction

11.18.4 Caerus Biotech Revenue in Infertility Services Business (2021–2026)

11.18.5 Caerus Biotech Recent Development

11.19 InVitroCare

11.19.1 InVitroCare Company Details

11.19.2 InVitroCare Business Overview

11.19.3 InVitroCare Infertility Services Introduction

11.19.4 InVitroCare Revenue in Infertility Services Business (2021–2026)

11.19.5 InVitroCare Recent Development

11.20 INVO Bioscience

11.20.1 INVO Bioscience Company Details

11.20.2 INVO Bioscience Business Overview

11.20.3 INVO Bioscience Infertility Services Introduction

11.20.4 INVO Bioscience Revenue in Infertility Services Business (2021–2026)

11.20.5 INVO Bioscience Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CARE facility

CooperSurgical

Ferring Pharmaceuticals

Monash IVF

Merck

Vitrolife AB

INVO Bioscience

Irvine Scientific

NMC Health

OB GYN Associates

TriHealth

Virtus Health

Mayo Clinic

LIVZON

Abbott

Theramex

Cinnagen

InVitroCare

Jinxin Fertility

Caerus Biotech

List of Tables

Table 1. Global Infertility Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Assisted Reproductive Technology (ART)

Table 3. Key Players of Infertility Drug Services

Table 4. Key Players of Others

Table 5. Global Infertility Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Infertility Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Infertility Services Market Size by Region (US$ Million), 2021–2026

Table 8. Global Infertility Services Market Share by Region (2021–2026)

Table 9. Global Infertility Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Infertility Services Market Share by Region (2027–2032)

Table 11. Infertility Services Market Trends

Table 12. Infertility Services Market Drivers

Table 13. Infertility Services Market Challenges

Table 14. Infertility Services Market Restraints

Table 15. Global Infertility Services Revenue by Players (US$ Million), 2021–2026

Table 16. Global Infertility Services Market Share by Players (2021–2026)

Table 17. Global Top Infertility Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Infertility Services Revenue, 2025

Table 18. Ranking of Global Top Infertility Services Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Infertility Services Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Infertility Services, Headquarters and Area Served

Table 21. Global Key Players of Infertility Services, Products and Applications

Table 22. Global Key Players of Infertility Services, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Infertility Services Market Size by Type (US$ Million), 2021–2026

Table 25. Global Infertility Services Revenue Market Share by Type (2021–2026)

Table 26. Global Infertility Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Infertility Services Revenue Market Share by Type (2027–2032)

Table 28. Global Infertility Services Market Size by Application (US$ Million), 2021–2026

Table 29. Global Infertility Services Revenue Market Share by Application (2021–2026)

Table 30. Global Infertility Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Infertility Services Revenue Market Share by Application (2027–2032)

Table 32. North America Infertility Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Infertility Services Market Size by Country (US$ Million), 2021–2026

Table 34. North America Infertility Services Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Infertility Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Infertility Services Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Infertility Services Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Infertility Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Infertility Services Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Infertility Services Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Infertility Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Infertility Services Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Infertility Services Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Infertility Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Infertility Services Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Infertility Services Market Size by Country (US$ Million), 2027–2032

Table 47. Ferring Pharmaceuticals Company Details

Table 48. Ferring Pharmaceuticals Business Overview

Table 49. Ferring Pharmaceuticals Infertility Services Product

Table 50. Ferring Pharmaceuticals Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 51. Ferring Pharmaceuticals Recent Development

Table 52. Merck Company Details

Table 53. Merck Business Overview

Table 54. Merck Infertility Services Product

Table 55. Merck Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 56. Merck Recent Development

Table 57. Jinxin Fertility Company Details

Table 58. Jinxin Fertility Business Overview

Table 59. Jinxin Fertility Infertility Services Product

Table 60. Jinxin Fertility Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 61. Jinxin Fertility Recent Development

Table 62. Vitrolife Company Details

Table 63. Vitrolife Business Overview

Table 64. Vitrolife Infertility Services Product

Table 65. Vitrolife Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 66. Vitrolife Recent Development

Table 67. Mayo Clinic Company Details

Table 68. Mayo Clinic Business Overview

Table 69. Mayo Clinic Infertility Services Product

Table 70. Mayo Clinic Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 71. Mayo Clinic Recent Development

Table 72. LIVZON Company Details

Table 73. LIVZON Business Overview

Table 74. LIVZON Infertility Services Product

Table 75. LIVZON Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 76. LIVZON Recent Development

Table 77. Abbott Company Details

Table 78. Abbott Business Overview

Table 79. Abbott Infertility Services Product

Table 80. Abbott Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 81. Abbott Recent Development

Table 82. Monash IVF Company Details

Table 83. Monash IVF Business Overview

Table 84. Monash IVF Infertility Services Product

Table 85. Monash IVF Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 86. Monash IVF Recent Development

Table 87. CARE Facility Company Details

Table 88. CARE Facility Business Overview

Table 89. CARE Facility Infertility Services Product

Table 90. CARE Facility Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 91. CARE Facility Recent Development

Table 92. Theramex Company Details

Table 93. Theramex Business Overview

Table 94. Theramex Infertility Services Product

Table 95. Theramex Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 96. Theramex Recent Development

Table 97. TriHealth Company Details

Table 98. TriHealth Business Overview

Table 99. TriHealth Infertility Services Product

Table 100. TriHealth Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 101. TriHealth Recent Development

Table 102. NMC Health Company Details

Table 103. NMC Health Business Overview

Table 104. NMC Health Infertility Services Product

Table 105. NMC Health Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 106. NMC Health Recent Development

Table 107. CooperSurgical Company Details

Table 108. CooperSurgical Business Overview

Table 109. CooperSurgical Infertility Services Product

Table 110. CooperSurgical Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 111. CooperSurgical Recent Development

Table 112. Irvine Scientific Company Details

Table 113. Irvine Scientific Business Overview

Table 114. Irvine Scientific Infertility Services Product

Table 115. Irvine Scientific Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 116. Irvine Scientific Recent Development

Table 117. Virtus Health Company Details

Table 118. Virtus Health Business Overview

Table 119. Virtus Health Infertility Services Product

Table 120. Virtus Health Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 121. Virtus Health Recent Development

Table 122. CinnaGen Company Details

Table 123. CinnaGen Business Overview

Table 124. CinnaGen Infertility Services Product

Table 125. CinnaGen Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 126. CinnaGen Recent Development

Table 127. OB GYN Associates Company Details

Table 128. OB GYN Associates Business Overview

Table 129. OB GYN Associates Infertility Services Product

Table 130. OB GYN Associates Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 131. OB GYN Associates Recent Development

Table 132. Caerus Biotech Company Details

Table 133. Caerus Biotech Business Overview

Table 134. Caerus Biotech Infertility Services Product

Table 135. Caerus Biotech Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 136. Caerus Biotech Recent Development

Table 137. InVitroCare Company Details

Table 138. InVitroCare Business Overview

Table 139. InVitroCare Infertility Services Product

Table 140. InVitroCare Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 141. InVitroCare Recent Development

Table 142. INVO Bioscience Company Details

Table 143. INVO Bioscience Business Overview

Table 144. INVO Bioscience Infertility Services Product

Table 145. INVO Bioscience Revenue in Infertility Services Business (US$ Million), 2021–2026

Table 146. INVO Bioscience Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

Table 150. Authors List of This Report

List of Figures

Figure 1. Infertility Services Picture

Figure 2. Global Infertility Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Infertility Services Market Share by Type: 2025 vs 2032

Figure 4. Assisted Reproductive Technology (ART) Features

Figure 5. Infertility Drug Services Features

Figure 6. Others Features

Figure 7. Global Infertility Services Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Infertility Services Market Share by Application: 2025 vs 2032

Figure 9. Male Case Studies

Figure 10. Female Case Studies

Figure 11. Infertility Services Report Years Considered

Figure 12. Global Infertility Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Infertility Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Infertility Services Market Share by Region: 2025 vs 2032

Figure 15. Global Infertility Services Market Share by Players in 2025

Figure 16. Global Infertility Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Infertility Services Revenue in 2025

Figure 18. North America Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Infertility Services Market Share by Country (2021–2032)

Figure 20. United States Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Infertility Services Market Share by Country (2021–2032)

Figure 24. Germany Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Infertility Services Market Share by Region (2021–2032)

Figure 32. China Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Infertility Services Market Share by Country (2021–2032)

Figure 40. Mexico Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Infertility Services Market Share by Country (2021–2032)

Figure 44. Israel Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Infertility Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Ferring Pharmaceuticals Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 48. Merck Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 49. Jinxin Fertility Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 50. Vitrolife Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 51. Mayo Clinic Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 52. LIVZON Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 53. Abbott Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 54. Monash IVF Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 55. CARE Facility Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 56. Theramex Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 57. TriHealth Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 58. NMC Health Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 59. CooperSurgical Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 60. Irvine Scientific Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 61. Virtus Health Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 62. CinnaGen Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 63. OB GYN Associates Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 64. Caerus Biotech Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 65. InVitroCare Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 66. INVO Bioscience Revenue Growth Rate in Infertility Services Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Male Infertility Testing Market Research Report 2024

Global Infertility Devices Market Insights Forecast to 2030

Global IVF Service Market Research Report 2024

Global Male Infertility Treatment Market Insights Forecast to 2030

In Vitro Fertilization IVF Treatment Market

Global Infertility Therapies Market Insights Forecast to 2030

Global In Vitro Fertilization Service Market Research Report 2025

Global Stem Cell Therapy for Infertility Market Research Report 2024

Global Ultrasound Infertility Diagnosis and Treatment Market Research Report 2022

Global Infertility Diagnosis Market Research Report 2024

Global Infertility Solutions Market Research Report 2025

Global In vitro Fertilization IVF Incubators Market Insights Forecast to 2030

Global Infertility Treatment Drugs Market Insights Forecast to 2030

Global Pet Reproductive Services Market Research Report 2024

Global Infertility Testing Market Research Report 2024

Global Male Infertility Market Research Report 2024

Assistive Reproductive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

IVF Devices and Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infertility Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions